Primary and Key Secondary Endpoints Met 77% of Patients Achieved Highly Statistically Significant Proptosis Response Study Showed Clinically Meaningful Reduction ...
A phase 3 trial of patients with moderate-to-severe TED has shown that subcutaneous injection of Tepezza by way of an on-body ...
OPDIVO is a prescription medicine used in combination with YERVOY as a first treatment to treat adults with cancer of the ...
Model estimates SUBLOCADE ® may reduce staff time and associated costs compared with other medications for opioid use disorder in jails and prisons ; RICHMOND, Va., March 31, 202 ...
A small device implanted just beneath the skin, roughly the size of a large postage stamp and weighing about two grams, kept ...
I read with great interest the study by Tiryaki et al., examining the effects of different intramuscular injection (IMI) sites—specifically, the ventrogluteal (VG) and vastus lateralis (VL) sites—on ...
SHANGHAI, March 09, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the ...
For a heart just damaged by a blocked artery, timing matters. So does access. That is what makes a new experimental treatment stand out: instead of being delivered directly to the heart, it is ...
VANCOUVER, BC, Dec. 16, 2025 /CNW/ -- Zephyrus Innovations (Zephyrus), a privately-owned medical device company designing and manufacturing safety syringes and Closed System Transfer Devices (CSTDs), ...
Cutaneous reactions associated with interferons (IFNs) treatment are either localized or generalized. The most common presentation of localized reactions at IFNs injection site is usually an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results